BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2199009)

  • 21. Allogeneic bone marrow transplantation for chronic myeloid leukemia in childhood: a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
    Millot F; Esperou H; Bordigoni P; Dalle JH; Michallet M; Michel G; Bourhis JL; Kuenz M; Blaise D; Garban F; Plouvier E; Rome A; Guilhot J; Guilhot F
    Bone Marrow Transplant; 2003 Nov; 32(10):993-9. PubMed ID: 14595387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allogeneic bone marrow transplantation: state of the art and future directions.
    Goldman JM
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():133-4. PubMed ID: 2653489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone marrow transplantation for chronic myeloid leukaemia using matched unrelated donors.
    Goldman JM; Mackinnon S
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():38-9. PubMed ID: 2627622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Allogeneic bone marrow transplantation in chronic myeloid leukemia. The clinical results and risk factors in 70 patients].
    Tomás JF; Peñarrubia MJ; García JA; Figuera A; Gómez-García de Soria V; Steegmann JL; Arranz R; Cámara R; Gabriel R; Vázquez L
    Med Clin (Barc); 1995 Nov; 105(16):605-11. PubMed ID: 8523939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unrelated donor and autologous marrow transplant therapy of chronic myelogenous leukemia (CML).
    McGlave P
    Leukemia; 1993 Jul; 7(7):1082-3. PubMed ID: 8321029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prior treatment with alpha-interferon does not adversely affect the outcome of allogeneic BMT in chronic phase chronic myeloid leukemia.
    Zuffa E; Bandini G; Bonini A; Santucci MA; Martinelli G; Rosti G; Testoni N; Zaccaria A; Tura S
    Haematologica; 1998 Mar; 83(3):231-6. PubMed ID: 9573677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation.
    De Witte T; Schattenberg A; Preijers F; Raymakers R; Muus P; Wessels J
    Bone Marrow Transplant; 1993; 12 Suppl 3():S2-6. PubMed ID: 8124252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Problems and strategies for bone marrow transplantation in acute leukemia and chronic myelogenous leukemia.
    Santos GW
    Cancer Detect Prev; 1988; 12(1-6):589-96. PubMed ID: 3052840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
    Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recipients of HLA-identical sibling marrow transplants with severe aplastic anemia engraft more quickly, and those with chronic myeloid leukemia more slowly, than those with acute leukemia.
    Atkinson K; Downs K; Ashby M; Dodds A; Concannon A; Biggs J
    Bone Marrow Transplant; 1989 Jan; 4(1):23-7. PubMed ID: 2647183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current status of bone marrow transplantation.
    Bortin MM; Horowitz MM
    Clin Transpl; 1989; ():93-104. PubMed ID: 2487630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells.
    Verdonck LF; Petersen EJ; Lokhorst HM; Nieuwenhuis HK; Dekker AW; Tilanus MG; de Weger RA
    Bone Marrow Transplant; 1998 Dec; 22(11):1057-63. PubMed ID: 9877267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allogeneic bone marrow transplantation for chronic myeloid leukemia. Working Party Chronic Leukemia of the European Group for Blood and Marrow Transplantation (EBMT).
    Gratwohl A; Hermans J
    Bone Marrow Transplant; 1996 May; 17 Suppl 3():S7-9. PubMed ID: 8769691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of unrelated bone marrow transplantation in the treatment of chronic myelogenous leukemia.
    Beatty PG
    Transfus Sci; 1991; 12(3):119-22. PubMed ID: 10149541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bone marrow transplantation for chronic myelogenous leukemia].
    Imanari A; Shibata A
    Nihon Rinsho; 1990 Sep; 48(9):2087-91. PubMed ID: 2232214
    [No Abstract]   [Full Text] [Related]  

  • 36. How do transplants cure chronic myelogenous leukemia?
    Gale RP; Butturini A
    Bone Marrow Transplant; 1992 Feb; 9(2):83-5. PubMed ID: 1571713
    [No Abstract]   [Full Text] [Related]  

  • 37. Keratoacanthoma ensuing from bone marrow transplantation for chronic myeloid leukemia.
    Furukawa M; Hamada T; Shibata H; Masaoka T
    Osaka City Med J; 1992 Jun; 38(1):83-8. PubMed ID: 1528582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapy for chronic myelogenous leukemia with marrow transplantation.
    Miller JS; McGlave PB
    Curr Opin Oncol; 1993 Mar; 5(2):262-9. PubMed ID: 8457612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic myelocytic leukemia: development of conditioning regimens for marrow transplantation.
    Storb R
    Leukemia; 1993 Aug; 7 Suppl 2():S135-7. PubMed ID: 8361218
    [No Abstract]   [Full Text] [Related]  

  • 40. Bone marrow transplantation for chronic myelogenous leukemia.
    Champlin R
    Curr Opin Oncol; 1990 Apr; 2(2):258-62. PubMed ID: 2095240
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.